Entry |
|
Symbol |
AKT3
|
Name |
(RefSeq) RAC-gamma serine/threonine-protein kinase isoform X1
|
KO |
|
Organism |
pcw Phascolarctos cinereus (koala)
|
Pathway |
pcw01521 | EGFR tyrosine kinase inhibitor resistance |
pcw04072 | Phospholipase D signaling pathway |
pcw04213 | Longevity regulating pathway - multiple species |
pcw04261 | Adrenergic signaling in cardiomyocytes |
pcw04550 | Signaling pathways regulating pluripotency of stem cells |
pcw04613 | Neutrophil extracellular trap formation |
pcw04620 | Toll-like receptor signaling pathway |
pcw04625 | C-type lectin receptor signaling pathway |
pcw04660 | T cell receptor signaling pathway |
pcw04662 | B cell receptor signaling pathway |
pcw04664 | Fc epsilon RI signaling pathway |
pcw04666 | Fc gamma R-mediated phagocytosis |
pcw04810 | Regulation of actin cytoskeleton |
pcw04914 | Progesterone-mediated oocyte maturation |
pcw04919 | Thyroid hormone signaling pathway |
pcw04920 | Adipocytokine signaling pathway |
pcw04923 | Regulation of lipolysis in adipocytes |
pcw04932 | Non-alcoholic fatty liver disease |
pcw04933 | AGE-RAGE signaling pathway in diabetic complications |
pcw04935 | Growth hormone synthesis, secretion and action |
pcw04973 | Carbohydrate digestion and absorption |
pcw05163 | Human cytomegalovirus infection |
pcw05166 | Human T-cell leukemia virus 1 infection |
pcw05167 | Kaposi sarcoma-associated herpesvirus infection |
pcw05168 | Herpes simplex virus 1 infection |
pcw05170 | Human immunodeficiency virus 1 infection |
pcw05207 | Chemical carcinogenesis - receptor activation |
pcw05208 | Chemical carcinogenesis - reactive oxygen species |
pcw05230 | Central carbon metabolism in cancer |
pcw05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
pcw05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:pcw00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
110205475 (AKT3)
04012 ErbB signaling pathway
110205475 (AKT3)
04014 Ras signaling pathway
110205475 (AKT3)
04015 Rap1 signaling pathway
110205475 (AKT3)
04370 VEGF signaling pathway
110205475 (AKT3)
04371 Apelin signaling pathway
110205475 (AKT3)
04630 JAK-STAT signaling pathway
110205475 (AKT3)
04668 TNF signaling pathway
110205475 (AKT3)
04066 HIF-1 signaling pathway
110205475 (AKT3)
04068 FoxO signaling pathway
110205475 (AKT3)
04072 Phospholipase D signaling pathway
110205475 (AKT3)
04071 Sphingolipid signaling pathway
110205475 (AKT3)
04024 cAMP signaling pathway
110205475 (AKT3)
04022 cGMP-PKG signaling pathway
110205475 (AKT3)
04151 PI3K-Akt signaling pathway
110205475 (AKT3)
04152 AMPK signaling pathway
110205475 (AKT3)
04150 mTOR signaling pathway
110205475 (AKT3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
110205475 (AKT3)
09143 Cell growth and death
04210 Apoptosis
110205475 (AKT3)
04218 Cellular senescence
110205475 (AKT3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
110205475 (AKT3)
04550 Signaling pathways regulating pluripotency of stem cells
110205475 (AKT3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
110205475 (AKT3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
110205475 (AKT3)
04613 Neutrophil extracellular trap formation
110205475 (AKT3)
04620 Toll-like receptor signaling pathway
110205475 (AKT3)
04625 C-type lectin receptor signaling pathway
110205475 (AKT3)
04660 T cell receptor signaling pathway
110205475 (AKT3)
04662 B cell receptor signaling pathway
110205475 (AKT3)
04664 Fc epsilon RI signaling pathway
110205475 (AKT3)
04666 Fc gamma R-mediated phagocytosis
110205475 (AKT3)
04062 Chemokine signaling pathway
110205475 (AKT3)
09152 Endocrine system
04910 Insulin signaling pathway
110205475 (AKT3)
04922 Glucagon signaling pathway
110205475 (AKT3)
04923 Regulation of lipolysis in adipocytes
110205475 (AKT3)
04920 Adipocytokine signaling pathway
110205475 (AKT3)
04929 GnRH secretion
110205475 (AKT3)
04915 Estrogen signaling pathway
110205475 (AKT3)
04914 Progesterone-mediated oocyte maturation
110205475 (AKT3)
04917 Prolactin signaling pathway
110205475 (AKT3)
04926 Relaxin signaling pathway
110205475 (AKT3)
04935 Growth hormone synthesis, secretion and action
110205475 (AKT3)
04919 Thyroid hormone signaling pathway
110205475 (AKT3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
110205475 (AKT3)
09154 Digestive system
04973 Carbohydrate digestion and absorption
110205475 (AKT3)
09156 Nervous system
04725 Cholinergic synapse
110205475 (AKT3)
04728 Dopaminergic synapse
110205475 (AKT3)
04722 Neurotrophin signaling pathway
110205475 (AKT3)
09158 Development and regeneration
04380 Osteoclast differentiation
110205475 (AKT3)
09149 Aging
04211 Longevity regulating pathway
110205475 (AKT3)
04213 Longevity regulating pathway - multiple species
110205475 (AKT3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
110205475 (AKT3)
05205 Proteoglycans in cancer
110205475 (AKT3)
05207 Chemical carcinogenesis - receptor activation
110205475 (AKT3)
05208 Chemical carcinogenesis - reactive oxygen species
110205475 (AKT3)
05230 Central carbon metabolism in cancer
110205475 (AKT3)
05231 Choline metabolism in cancer
110205475 (AKT3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
110205475 (AKT3)
09162 Cancer: specific types
05210 Colorectal cancer
110205475 (AKT3)
05212 Pancreatic cancer
110205475 (AKT3)
05225 Hepatocellular carcinoma
110205475 (AKT3)
05226 Gastric cancer
110205475 (AKT3)
05214 Glioma
110205475 (AKT3)
05221 Acute myeloid leukemia
110205475 (AKT3)
05220 Chronic myeloid leukemia
110205475 (AKT3)
05218 Melanoma
110205475 (AKT3)
05211 Renal cell carcinoma
110205475 (AKT3)
05215 Prostate cancer
110205475 (AKT3)
05213 Endometrial cancer
110205475 (AKT3)
05224 Breast cancer
110205475 (AKT3)
05222 Small cell lung cancer
110205475 (AKT3)
05223 Non-small cell lung cancer
110205475 (AKT3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
110205475 (AKT3)
05170 Human immunodeficiency virus 1 infection
110205475 (AKT3)
05161 Hepatitis B
110205475 (AKT3)
05160 Hepatitis C
110205475 (AKT3)
05164 Influenza A
110205475 (AKT3)
05162 Measles
110205475 (AKT3)
05168 Herpes simplex virus 1 infection
110205475 (AKT3)
05163 Human cytomegalovirus infection
110205475 (AKT3)
05167 Kaposi sarcoma-associated herpesvirus infection
110205475 (AKT3)
05169 Epstein-Barr virus infection
110205475 (AKT3)
05165 Human papillomavirus infection
110205475 (AKT3)
09171 Infectious disease: bacterial
05132 Salmonella infection
110205475 (AKT3)
05135 Yersinia infection
110205475 (AKT3)
05152 Tuberculosis
110205475 (AKT3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
110205475 (AKT3)
05142 Chagas disease
110205475 (AKT3)
09164 Neurodegenerative disease
05010 Alzheimer disease
110205475 (AKT3)
05017 Spinocerebellar ataxia
110205475 (AKT3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
110205475 (AKT3)
05418 Fluid shear stress and atherosclerosis
110205475 (AKT3)
05415 Diabetic cardiomyopathy
110205475 (AKT3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
110205475 (AKT3)
04932 Non-alcoholic fatty liver disease
110205475 (AKT3)
04931 Insulin resistance
110205475 (AKT3)
04933 AGE-RAGE signaling pathway in diabetic complications
110205475 (AKT3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
110205475 (AKT3)
01524 Platinum drug resistance
110205475 (AKT3)
01522 Endocrine resistance
110205475 (AKT3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:pcw01001]
110205475 (AKT3)
Enzymes [BR:pcw01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
110205475 (AKT3)
Protein kinases [BR:pcw01001]
Serine/threonine kinases: AGC group
AKT/PKB family
110205475 (AKT3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
536 aa
MSDVTIVKEGWVQKRGEYIKNWRPRYFLLKTDGSFIGYKEKPQDVDLPYPLNNFSVAKSE
TSPNNTTFWSLKSFLGMHCLNHSRGKEAYQLRRKPSYFSIVYRTLGGECQLMKTERPKPN
TFIIRCLQWTTVIERTFHVDTPEERSLAFFFLEEWTEAIQAVADRLQRQEEERMNCSPTS
QIDNIGEEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILKKEV
IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVF
SEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM
KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI
KFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFVGVNWQDVYDKKLVPPFK
PQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQFSYSASGRE |
NT seq |
1611 nt +upstreamnt +downstreamnt
atgagcgatgttaccattgtgaaagaaggttgggttcagaagaggggagaatatataaaa
aactggaggccaagatacttccttttgaagacagatggctcattcataggatataaggag
aaacctcaagatgtggatttaccttatccccttaacaacttttcagtggcaaaaagtgaa
acatctcccaacaatactaccttttggtcactgaagtcttttctggggatgcattgtctg
aaccattccagaggcaaagaagcctaccagttgaggaggaaaccaagctatttctccatt
gtatacagaactcttggaggggaatgccaactcatgaaaacagaacgaccaaagccaaat
acatttattatcagatgcctccagtggaccactgttatagaacgaacatttcatgtggat
actccagaggaaaggtcacttgcttttttttttttggaagaatggacagaagctatccag
gctgtagcagacagacttcagaggcaagaagaagagagaatgaactgtagtccgacttca
caaattgataatataggagaggaggaaatggatgcttctacaactcatcataaaagaaag
acaatgaatgactttgactatttgaaactgttgggtaaaggcacttttggaaaagtgatt
ttggttcgagagaaggcaagtggaaaatattatgctatgaagattttgaagaaagaagta
attattgcaaaggatgaagtggcacatactctaacagaaagcagagtattaaaaaacact
aggcacccctttttaacttctttgaaatattccttccagacaaaagatcgtttgtgtttt
gtgatggagtatgttaatggaggagagctgtttttccatttgtcgagagagcgggtgttc
tctgaggaccgcacacgcttctatggtgcagaaattgtctcagctttggactatctacat
tctggaaagattgtgtaccgtgatctcaagttggaaaatttgatgttggataaagatggc
cacataaaaattacagattttggactttgcaaagaagggattacagatgcagctacgatg
aagacattttgtggtacacctgagtaccttgcacctgaggtattagaagataatgactat
ggccgtgcagtagactggtggggcctgggggttgtcatgtatgaaatgatgtgtgggaga
ttaccattctacaaccaggatcatgagaaactttttgagctaatattaatggaggacatt
aaatttcctcgaactctttcttctgatgcaaaatccttactttcaggactcttaataaaa
gatccaaataaacgccttggcggaggtccagatgatgcaaaagaaattatgaggcatagt
ttctttgttggagtaaactggcaagatgtatatgataaaaagctggtacctccttttaaa
cctcaagtaacgtctgagacagacaccagatattttgatgaagaatttacagctcagaca
attacaataacaccgcctgaaaaatatgatgaggatggtatggactgcatggacaatgag
agacggccacatttcccacagttttcctactctgcaagtggacgagaataa |